These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 36894324)
21. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies. Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738 [TBL] [Abstract][Full Text] [Related]
22. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates. Acchione M; Kwon H; Jochheim CM; Atkins WM MAbs; 2012; 4(3):362-72. PubMed ID: 22531451 [TBL] [Abstract][Full Text] [Related]
23. Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins. Spidel JL; Albone EF; Cheng X; Vaessen B; Jacob S; Milinichik AZ; Verdi A; Kline JB; Grasso L MAbs; 2017; 9(6):907-915. PubMed ID: 28541812 [TBL] [Abstract][Full Text] [Related]
25. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. Kumar A; Mao S; Dimasi N; Gao C Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794 [TBL] [Abstract][Full Text] [Related]
26. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis. Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090 [TBL] [Abstract][Full Text] [Related]
27. Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates. Kaempffe A; Dickgiesser S; Rasche N; Paoletti A; Bertotti E; De Salve I; Sirtori FR; Kellner R; Könning D; Hecht S; Anderl J; Kolmar H; Schröter C J Pharm Sci; 2021 Dec; 110(12):3776-3785. PubMed ID: 34363839 [TBL] [Abstract][Full Text] [Related]
28. Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase. El Alaoui M; Sivado E; Jallas AC; Mebarki L; Dyson MR; Perrez F; Valsesia-Wittmann S; El Alaoui S Cell Death Discov; 2024 Feb; 10(1):79. PubMed ID: 38360912 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody-Drug Conjugates. Yang Q; Chen H; Ou C; Zheng Z; Zhang X; Liu Y; Zong G; Wang LX Antibodies (Basel); 2023 Nov; 12(4):. PubMed ID: 37987249 [TBL] [Abstract][Full Text] [Related]
30. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates. Farias SE; Strop P; Delaria K; Galindo Casas M; Dorywalska M; Shelton DL; Pons J; Rajpal A Bioconjug Chem; 2014 Feb; 25(2):240-50. PubMed ID: 24359082 [TBL] [Abstract][Full Text] [Related]
31. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry. Pan LY; Salas-Solano O; Valliere-Douglass JF Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577 [TBL] [Abstract][Full Text] [Related]
32. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass. Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287 [TBL] [Abstract][Full Text] [Related]